Results 101 to 110 of about 39,119 (216)

Conservative management of paediatric dacryocystitis: a collection of clinical experiences highlighting effectiveness and parental satisfaction

open access: yesDrugs in Context
Paediatric dacryocystitis, often linked to congenital nasolacrimal duct obstruction, may require surgical intervention if local conservative treatment is ineffective.
Stefano Russo   +4 more
doaj   +1 more source

Suppressed intestinal secondary bile acids in moxifloxacin-induced hyperglycemia: studies in normal and diabetic GK rats

open access: yesFrontiers in Pharmacology
ObjectiveMoxifloxacin (MFLX) frequently induces dysglycemia when used in the treatment of infectious diseases, particularly in patients with diabetes. However, the mechanism through which MFLX affects host glucose metabolism remains unclear.
Yewen Sun   +12 more
doaj   +1 more source

The Role of Chest Radiograph, Procalcitonin and Moxifloxacin in Diagnosis and Management of Breast Cancer Patients with COVID-19

open access: yesActa Medica Indonesiana, 2020
Global widespread of current coronavirus disease 2019 (COVID-19) pandemic has emerged huge predicament to healthcare systems globally. This disease caused by a new beta-type coronavirus, known as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-
Ikhwan Rinaldi   +7 more
doaj  

Sustained-Release Biodegradable Intracameral Implants Containing Dexamethasone and Moxifloxacin: Development and In Vivo Primary Assessment

open access: yesPharmaceutics
Background/Objectives: We report the development of a novel intraocular sustained-release implantable pharmaceutical formulation, designed to be placed in the anterior chamber of the eye after cataract surgery.
Pablo Miranda   +7 more
doaj   +1 more source

Hepatic safety of pretomanid- and pyrazinamide-containing regimens in TB Alliance clinical trials

open access: yesIJTLD Open
BACKGROUND: In STAND and SimpliciTB, clinical trials for drug-susceptible TB, regimens containing pretomanid, pyrazinamide, and other agents (PaZX) had more hepatotoxicity than the standard-of-care regimen of isoniazid, rifampicin, pyrazinamide, and ...
J. Nedelman   +9 more
doaj   +1 more source

Topical Antibiotic Therapy in the Ocular Environment: The Benefits of Using Moxifloxacin Eyedrops

open access: yesMicroorganisms
Moxifloxacin is a fourth-generation fluoroquinolone antibiotic available for ophthalmic use. It inhibits two enzymes involved in bacterial DNA synthesis, covering Gram-positive and Gram-negative pathogens. This spectrum allows for the formulation of self-
Lorenzo Drago
doaj   +1 more source

Moxifloxacin Induced Seizures -A Case Report.

open access: yesIranian Journal of Public Health, 2014
A 73-year-old female patient developed a generalized tonic-clonic seizure on the 6th day after treatment with moxifloxacin 400 mg daily intravenously for appendicitis.
Jiana Shi, Huimin Xu
doaj  

Comparative analysis of the safety and efficacy of intracameral cefuroxime, moxifloxacin and vancomycin at the end of cataract surgery: a meta-analysis

open access: yesBritish Journal of Ophthalmology, 2018
R. Bowen   +13 more
semanticscholar   +1 more source

Efficacy of intracameral moxifloxacin in prevention of postcataract surgery endophthalmitis: randomized control trial. [PDF]

open access: yesJ Cataract Refract Surg
Sharma N   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy